Caladrius Biosciences

- NASDAQ:CLBS
Last Updated 2021-07-24
  • Caladrius Biosciences, Inc., through its subsidiary, PCT, is a leading development and manufacturing partner to the cell therapy industry.
  • Locations

    • New York NY
    • Basking Ridge NJ
  • Total Funding (USD)

    63.5 million
  • Industries

    Real Estate, Mobile Apps, Cyber Security
  • Acquisitions (4)

    • California Stem Cell (2014)
    • Amorcyte (2011)
    • PCT Cell Therapy Services (2011)
    • Progenitor Cell Therapy (2011)
  • Security

    Type: ORD
    CUSIP: 128058203
    ISIN: US1280582032
Filter date
All
Bookmark Created by Last updated
There were no results found.
Filter date
All
Article Author Published
There were no results found.

Request a demo to view additional historical data, and much more.